AF
ANAB icon

Amalgamated Financial’s AnaptysBio ANAB Stock Holding History

Amalgamated Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$57K Buy
+2,321
New +$70.2K ﹤0.01% 2358

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amalgamated Financial's ANAB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in AnaptysBio (ANAB) in Q1 2022: 2,321 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings.

131 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

  • Amalgamated Financial held 2,321 shares of AnaptysBio worth $57K as of Q1 2022.
  • AnaptysBio was a new Amalgamated Financial position in Q1 2022.
  • AnaptysBio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2358 holding.
  • 131 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.